Coloplast Introduces SeaSorb®-Ag Alginate Dressing
Coloplast Corp. (Marietta, Ga) introduces SeaSorb®-Ag Alginate Dressing with Silver. SeaSorb-Ag is identical to SeaSorb Soft alginate dressing only it has the added antimicrobial benefit of silver.
SeaSorb-Ag utilizes a mix of calcium alginate and highly absorbent carboxymethylcellulose with the addition of an ionic silver complex that releases silver ions in the presence of wound exudate. As exudate is absorbed, the dressing forms a soft, cohesive gel that intimately conforms to the wound surface, maintaining an optimal moist wound-healing environment.
The dressing is indicated for moderate to heavily exuding partial- to full-thickness wounds including post-operative wounds, trauma wounds, leg ulcers, pressure ulcers, diabetic ulcers, and graft and donor sites. The dressing is ideal for cavity wounds.
The dressing provides clinicians superior absorption performance and exudate management. This dressing provides 33% greater absorption than the leading silver dressing. The high retention capabilities also lock exudate away from the periwound area.
Call 800-533-0464 or visit http://www.us.coloplast.com for more information.
3M™ Tegaderm™ Acrylic Dressing Provides Simple and Effective Treatment of Sacral Wounds 3M (St. Paul, Minn) introduces the addition of a sacral shape wound dressing to the 3M™ Tegaderm™ Absorbent Clear Acrylic Dressing line. The new sacral shape dressing is designed to facilitate sacral site wound monitoring and absorbent capabilities necessary for fluid management. This dressing gives clinicians a new option for effective, simple, and dependable wound treatment.
The new sacral design builds on a line of absorbent clear acrylic dressings that offer additional benefits compared to other commonly used dressings. According to a recent study evaluating Stage II and III pressure ulcers, Tegaderm Absorbent rated significantly better than the leading hydrocolloid dressing on a variety of comparison points, including:
• Ability to assess the wound before and after absorption
• Wear time
• Patient comfort
• Presence of residue on the skin or in the wound
• Odor reduction.
Study results showed that the dressing retained all the positive features of hydrocolloid dressings while improving on inherent limitations including lack of transparency, wear time, residue, and odor. These features may facilitate fewer dressing changes, improving nursing productivity and overall treatment cost.
The clear layer of the sacral shape dressing allows clinicians to monitor sacral wound progress before and after absorption. It also may eliminate unscheduled dressing changes, saving valuable time and money and providing better patient comfort. The absorbent layer provides a moist wound environment, promoting autolytic wound debridement.
Visit http://www.3m.com/Tegaderm or call 800-228-3957 for more information.
Epi-Max Wound Dressing Evaluation Results are Promising Epi-Max (Greystone Pharmaceuticals, Memphis, Tenn), an acetylated regenerated cellulose (ARC) sterile wound dressing, is a prescription combination device that provides the benefits of an innovative wound dressing with dual active ingredients. It is indicated for use to manage pressure ulcers (Stage I through Stage IV), stasis ulcers, diabetic skin ulcers, skin irritations, cuts, and abrasions.
The dressing was developed from many years of studies and observations of chronic wound environments and inorganic mineral effects on epidermal tissues. The regenerated cellulose dressing treatment combines a moist ointment with 2 active ingredients (as listed on the product label) to create a normalized wound bed environment for previously damaged tissue.
Call 800-814-3091 or email shadley@greystonepharmaceuticals.com for more information.
AcryMed Oxygenated Dressings May Offer Alternative to Hyperbaric Oxygen Therapy New technology from AcryMed (Portland, Ore) that delivers oxygen directly to the wound site to promote healing was revealed at the Wound Healing Society Meeting held May 14–17 in Scottsdale, Ariz. Dr. David Roe, the lead scientist for the oxygen therapy development program, publicly presented research results from tests on wound dressings that incorporate oxygen-delivering technology.
Research has shown that an increase in dissolved oxygen in wounds is beneficial for promoting the closure of wounds, such as diabetic foot ulcers. To date, the only effective way to accomplish this clinically has been through the use of hyperbaric oxygen chambers. Due to the cost and inconvenience of these chambers, there has been high interest in the development of alternative technology that provides topically delivered oxygen directly to the wound. Currently, the technologies that have evolved have relied on the topical administration of gaseous oxygen—a form of oxygen that has not been proven effective in wound healing.
Visit http://www.AcryMed.com for more information.
|
